You are here: Industry Insights > BioNTech

News List

Over a quarter of UK adults have received both COVID-19 vaccine doses pharmatimes
April 28, 2021
The Department of Health and Social Care (DHSC) has announced that over a quarter of adults in the UK have now received both doses of a COVID-19 vaccine in the latest vaccination milestone.
Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine pharmaceutical-technology
April 27, 2021
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle called ‘myocarditis’ in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
Start of Production in Record Time: Evonik Delivers First Lipids from German Facility to BioNTech americanpharmaceuticalreview
April 23, 2021
Evonik is helping to accelerate the production of the COVID-19 vaccine from Pfizer-BioNTech by suppling an essential component. Evonik is delivering first batches of the urgently needed lipids for the mRNA-based vaccine to BioNTech months earlier than ...
New advice on COVID-19 vaccination for pregnant women in UK pharmatimes
April 20, 2021
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that pregnant women in the UK be offered COVID-19 vaccination at the same time as the rest of the population.
Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU contractpharma
April 20, 2021
EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.
Pfizer/BioNTech’s vaccine to touch sales of $24.8 billion by 2021: GlobalData expresspharma
April 15, 2021
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the market. This is a 20 per cent increase over Humira’s peak sales of $20.5 billion, suggesting that Comirnaty could be the ...
COVAX has delivered vaccines to over 100 countries, despite supply hits: GAVI/WHO expresspharma
April 09, 2021
The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.
EU countries consent to share COVID-19 vaccines with member states in need expresspharma
April 06, 2021
Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10 million doses.
Pfizer and BioNTech’s Covid-19 vaccine shows 100% efficacy in adolescents pharmaceutical-technology
April 02, 2021
Pfizer and BioNTech have reported that a Phase III trial of their Covid-19 vaccine, BNT162b2, showed 100% efficacy and strong antibody responses in adolescents aged 12 to 15 years with or without prior evidence of SARS-CoV-2 infection.
Pfizer COVID-19 vaccine safe, efficacious for adolescents expresspharma
April 02, 2021
Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page